Contact:Consumer:1-888-816-8804Media:Amélie GermainDirector of CommunicationsT : 418 652-1173 x330 ag@atrium-innovations.com
FOR IMMEDIATE RELEASE – July 10, 2012 – Sedona Labs today announced that its supplier of Galactooligosaccharide (GOS) has recalled this ingredient due to a possible Salmonella contamination. As a result, we are now voluntarily recalling certain lots of our iFlora® Kids Multi-Probiotic® distributed between 3/16/2011 and 5/3/2012. The following lots with their corresponding UPC codes are included in the recall:
Lot Number
UPC Code
1074711
6 48575 01013 2
1479611
6 48575 01013 2
1640811
6 48575 01013 2
1734411
6 48575 01013 2
1595811 and 2089411
6 48575 01014 9
Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.
Customers possessing these products should immediately discontinue their use. To date, no illnesses have been reported in connection with the iFlora® Kids Multi-Probiotic®.
No other Sedona Labs products are involved or impacted.
iFlora® Kids Multi-Probiotic® has been sold throughout the US to health food stores and internet retailers and sold via health care professionals.
Any consumers who wish to return iFlora® Kids Multi-Probiotic® may return the product to the place of purchase for a full refund. Questions may be directed to the company at 1-888-816-8804, Monday-Friday between the hours of 7:00 AM and 3:00 PM PST.
About Sedona LabsSedona Labs is a subsidiary of Nutri-Health Supplements LLC, a wholly owned division of Atrium Innovations Inc. (TSX: ATB), a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based dietary supplements available mainly through healthcare practitioners and health food and specialized stores. Atrium has over 1,100 employees and operates eight manufacturing facilities. Additional information is available at https://www.atrium-innovations.com.
Leave a Reply